VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G

Company

Apellis Pharmaceuticals, Inc.

Filed

February 9, 2018

Accession Number

0001072613-18-000100

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →